Showing results (361-370 of 458) with videos related to
Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2006
Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastomaChristina M Coughlin, Mark D Fleming, Richard G Carroll, et al.Cell Reports|March 7, 2024
ALK upregulates POSTN and WNT signaling to drive neuroblastomaMiller Huang, Wanqi Fang, Alvin Farrel, et al.Cell Reports|August 4, 2023
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastomaMiriam I Rosenberg, Erez Greenstein, Martin Buchkovich, et al.Genome Medicine|May 29, 2019
Clinical utility of custom-designed NGS panel testing in pediatric tumorsLea F Surrey, Suzanne P MacFarland, Fengqi Chang, et al.Biorxiv : the Preprint Server for Biology|June 4, 2026
A generalizable system for antigenic peptide targeting across HLA-I allotypesWyatt Blackson, Ean L Small, Shirley M Sun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2020
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology GroupRajen Mody, Alice L Yu, Arlene Naranjo, et al.B-ENT|February 26, 2013
Specific medical and surgical treatment for chronic inflammatory diseases in childrenA Boudewyns, J Antunes, N Bernheim, et al.Journal for Immunotherapy of Cancer|February 23, 2023
KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology GroupAmy K Erbe, Mitch B Diccianni, Rajen Mody, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II studySuzanne Shusterman, Wendy B London, Stephen D Gillies, et al.Science Advances|January 1, 2026
HLA-Shuttle: A system for enhancing antigen presentation in immunologically cold tumorsDaniel Hwang, Molly C Erdman, Santosh Adhikari, et al.Pageof 46